Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD.

Dibba P, Li AA, Perumpail BJ, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A.

Diseases. 2018 Sep 19;6(3). pii: E83. doi: 10.3390/diseases6030083. Review.

2.

Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016.

Li AA, Kim D, Kim W, Dibba P, Wong K, Cholankeril G, Jacobson IM, Younossi ZM, Ahmed A.

J Viral Hepat. 2018 Dec;25(12):1608-1616. doi: 10.1111/jvh.12981. Epub 2018 Sep 11.

PMID:
30112849
3.

The Role of Cannabinoids in the Setting of Cirrhosis.

Dibba P, Li AA, Cholankeril G, Iqbal U, Gadiparthi C, Khan MA, Kim D, Ahmed A.

Medicines (Basel). 2018 Jun 9;5(2). pii: E52. doi: 10.3390/medicines5020052. Review.

4.

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease.

Dibba P, Li A, Cholankeril G, Iqbal U, Gadiparthi C, Khan MA, Kim D, Ahmed A.

Medicines (Basel). 2018 May 28;5(2). pii: E47. doi: 10.3390/medicines5020047. Review.

5.

Case Report of Isoniazid-Related Acute Liver Failure Requiring Liver Transplantation.

Li AA, Dibba P, Cholankeril G, Kim D, Ahmed A.

Diseases. 2018 May 19;6(2). pii: E40. doi: 10.3390/diseases6020040.

6.

Hepatitis C in Pregnancy.

Dibba P, Cholankeril R, Li AA, Patel M, Fayek M, Dibble C, Okpara N, Hines A, Ahmed A.

Diseases. 2018 Apr 27;6(2). pii: E31. doi: 10.3390/diseases6020031.

Supplemental Content

Loading ...
Support Center